Thioflavin T fluorescence in human serum: Correlations with vascular health and cardiovascular risk factors

Clinical Biochemistry

Volumn 43, Issue 3, 2010, Pages 278-286

  Griffin, Michael D W ^a   Wilson, Leanne M ^a   Mok, Yee Foong ^a   Januszewski, Andrzej S ^b   Wilson, Andrew M ^b   Karschimkus, Connie S ^b   Romas, Evange ^b,c   Lee, Allan B ^b   Godfrey, Tim ^c   Wong, Melinda ^c   Clemens, Laurence ^c   Jenkins, Alicia J ^b   Howlett, Geoffrey J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Advanced glycation end product; AGE; Amadori product; Apolipoprotein; Protein glycation

Indexed keywords

ALBUMIN; AMYLOID; AMYLOID PROTEIN; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; GLYCOSYLATED ALBUMIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLGLYOXAL; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOFLAVINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHEMICAL MODIFICATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ELASTICITY; FEMALE; FLOTATION; FLUORESCENCE; HUMAN; INFLAMMATION; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROTEIN STRUCTURE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ADULT; AMYLOID BETA-PROTEIN; ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CATTLE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PYRUVALDEHYDE; RISK FACTORS; SERUM ALBUMIN; THIAZOLES;

EID: 74249095703     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.10.010     Document Type: Article

References (24)

1. Dobson C.M. Getting out of shape. Nature 418 (2002) 729-730
2. Howlett G.J., and Moore K.J. Untangling the role of amyloid in atherosclerosis. Curr Opin Lipidol 17 (2006) 541-547
3. Haggqvist B., Naslund J., Sletten K., et al. Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci U S A 96 (1999) 8669-8674
4. Stewart C.R., Haw A., Lopez R., et al. Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications. J Lipid Res 48 (2007) 2162-2171
5. Jenkins A.J., Best J.D., Klein R.L., and Lyons T.J. Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes Metab Res Rev 20 (2004) 349-368
6. Lee A.B., Godfrey T., Rowley K.G., et al. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Intern Med J 36 (2006) 237-243
7. Wilson A.M., O'Neal D., Nelson C.L., Prior D.L., Best J.D., and Jenkins A.J. Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens 17 (2004) 285-291
8. Wong M., Toh L., Wilson A., et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 48 (2003) 81-89
9. Medeiros L.A., Khan T., El Khoury J.B., et al. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J Biol Chem 279 (2004) 10643-10648
10. Moore K.J., El Khoury J., Medeiros L.A., et al. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem 277 (2002) 47373-47379
11. Stewart C.R., Wilson L.M., Zhang Q., et al. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation. Biochemistry 46 (2007) 5552-5561
12. Stewart C.R., Tseng A.A., Mok Y.F., et al. Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages. Biochemistry 44 (2005) 9108-9116
13. Bouma B., Kroon-Batenburg L.M., Wu Y.P., et al. Glycation induces formation of amyloid cross-beta structure in albumin. J Biol Chem 278 (2003) 41810-41819
14. Singh R., Barden A., Mori T., and Beilin L. Advanced glycation end-products: a review. Diabetologia 44 (2001) 129-146
15. Ramasamy R., Yan S.F., and Schmidt A.M. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc Med 15 (2005) 237-243
16. Wautier J.L., and Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95 (2004) 233-238
17. Jakus V., and Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 53 (2004) 131-142
18. Schumaker V.N., and Puppione D.L. Sequential flotation ultracentrifugation. Methods Enzymol 128 (1986) 155-170
19. Knecht K.J., Dunn J.A., McFarland K.F., et al. Effect of diabetes and aging on carboxymethyl lysine levels in human urine. Diabetes 40 (1991) 190-196
20. Grey E., Bratteli C., Glasser S.P., et al. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. Am J Hypertens 16 (2003) 265-269
21. Bourajjaj M., Stehouwer C.D., van Hinsbergh V.W., and Schalkwijk C.G. Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem Soc Trans 31 (2003) 1400-1402
22. Lerch P.G., Fortsch V., Hodler G., and Bolli R. Production and characterization of a reconstituted high density lipoprotein for therapeutic applications. Vox Sang 71 (1996) 155-164
23. LeVine H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309 (1999) 274-284
24. Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 844-848